mds-news - HealthTree for MDS

New in MDS

Here you will find articles that discuss the latest advances in MDS. You will be kept up to date on the newest FDA drug approvals for MDS drugs and treatment combinations. You will also learn about newly published research studies and any advances or findings that may contribute to your MDS treatment. We will discuss topics such as newly discovered MDS genetic mutations, exciting advances on new therapies like CAR-T therapy and NK cells, and improvements in allogeneic stem cell transplant.

Articles posted here will also aim to help answer common questions like "how is MDS treated?", "how is MDS diagnosed?", and "what causes MDS?".

With new MDS research being published almost every day, there is a lot to keep track of. The articles in this category will help you stay informed of new MDS treatment options and MDS research findings which will ultimately make you an empowered patient. Being empowered allows you to take important information to your healthcare team for discussion that will further enhance and personalize your care.

Omidubicel Granted FDA Approval For Use In Stem Cell Transplants

May 23, 2023

For more than 30 years, umbilical cord blood (UCB) has been an important stem cell source for patients with leukemia, lymphoma and MDS

Dr. Sekeres - Improving Treatment for Myelodysplastic Syndromes (MDS)

May 02, 2023

Dr. Sekeres shared with us what he and his MDS colleagues are focusing their research on right now.

Dr. Chandhok - Improving Drug Efficacy for Underserved Populations

April 25, 2023

Dr. Chandhok is doing important research into improving drug efficacy for underserved populations.

Dr. Tinsley Vance - Improving Patient Treatment Experience

April 18, 2023

The work Dr. Tinsley Vance is doing is important and will have a big impact on the way we look at patient decision making and our support of caregivers.